FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely a pharmaceutical composition containing Polysorbate 80, anhydrous docetaxel (I) or its trihydrate and organic acid used as a degradation inhibitor and characterised by pH value within 2.5-4.5.
EFFECT: pharmaceutical compositions of at least 30 months of storage at room temperature understood as temperature within the range 15-30°C±1°C, provide sterility and stability, as well as low concentration of 7-epi-docetaxel(II).
13 cl, 2 tbl, 6 ex
